Trial intelligence / Profile preview

Early versus late initiation of Risperdal Consta after an acute episode in schizophrenia or schizoaffective disorder

2005-002304-41Phase 4Completed

Sponsor
Janssen Pharmaceutical
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of risperidone in schizophrenia and schizoaffective disorder (2 arms), sponsored by Janssen Pharmaceutical. Started Jul 2005; status: completed.

02

Drugs

risperidone
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on 2005-002304-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002304-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call